{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30622966", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "24"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "11", "Day": "28"}], "Language": ["eng"], "ELocationID": ["9504158", "10.1155/2018/9504158"], "Journal": {"ISSN": "2314-6141", "JournalIssue": {"Volume": "2018", "PubDate": {"Year": "2018"}}, "Title": "BioMed research international", "ISOAbbreviation": "Biomed Res Int"}, "ArticleTitle": "Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells.", "Pagination": {"StartPage": "9504158", "MedlinePgn": "9504158"}, "Abstract": {"AbstractText": ["Hypoxia-induced pulmonary hypertension (HPH) is a severe condition associated with significant morbidity and mortality in people living at high altitude. Tsantan Sumtang, a traditional Tibetan medicine, has been routinely used for the treatment of cardiopyretic disease, as well as stenocardia. Interestingly, our previous research found that Tsantan Sumtang improved HPH in rats maintaining in a hypobaric chamber. We performed a series of experiments to test the indexes of vasoconstriction and vascular remodeling, the key pathophysiological characteristics of HPH. Our results showed that Tsantan Sumtang relaxed noradrenaline (NE)-precontracted rat pulmonary artery rings in a concentration-dependent manner <i>in vitro</i>. The PGI2-cAMP (prostaglandin I2-cyclic adenosine monophosphate) pathway, NO-cGMP (nitric oxide-cyclic guanosine monophosphate) pathway, and the opening of K<sup>+</sup> channels (inward rectifier K<sup>+</sup> channels, large conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels, and voltage-dependent K<sup>+</sup> channels) might play major roles in the vasorelaxation effect. <i>In vivo</i>, the administration of Tsantan Sumtang resulted in a substantial decrease in the rat mean pulmonary artery pressure (mPAP) and the right ventricular hypertrophy index (RVHI). The reduction of thickness of small pulmonary arterial wall and the WT% (the ratio of the vascular wall thickness to the vascular diameter) were observed. The smooth muscle muscularization of the arterials was alleviated by Tsantan Sumtang treatment at the same time. Tsantan Sumtang also reduced remodeling of pulmonary arterioles by suppressing the expression of proliferating cell nuclear antigen (PCNA), <i>\u03b1</i>-smooth muscle actin (<i>\u03b1</i>-SMA), cyclin D1, and cyclin-dependent kinase 4 (CDK4) through inhibition of p27Kip1 degradation. Therefore, Tsantan Sumtang could be applied as a preventative medication for HPH, which would be a new use for this traditional medicine."]}, "AuthorList": [{"Identifier": ["0000-0001-7928-1244"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Medical Department, Medical College, Qinghai University, Xining 810001, China."}], "LastName": "He", "ForeName": "Qilian", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}], "LastName": "Nan", "ForeName": "Xingmei", "Initials": "X"}, {"Identifier": ["0000-0002-4543-1141"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Ha'erbin 150040, China."}], "LastName": "Li", "ForeName": "Silin", "Initials": "S"}, {"Identifier": ["0000-0001-7808-8266"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Qinghai Entry-Exit Inspection and Quarantine Bureau, Xining 810003, China."}], "LastName": "Su", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}], "LastName": "Ma", "ForeName": "Ke", "Initials": "K"}, {"Identifier": ["0000-0002-6482-3255"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}], "LastName": "Li", "ForeName": "Zhanqiang", "Initials": "Z"}, {"Identifier": ["0000-0001-5677-2833"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}], "LastName": "Lu", "ForeName": "Dianxiang", "Initials": "D"}, {"Identifier": ["0000-0003-0615-7060"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for High Altitude Medicine, Qinghai University, Xining 810001, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Application and Foundation for High Altitude Medicine Research in Qinghai Province, Xining 810001, China."}], "LastName": "Ge", "ForeName": "Rili", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biomed Res Int", "NlmUniqueID": "101600173"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": ["drug therapy", "etiology", "metabolism", "physiopathology"], "DescriptorName": "Hypertension, Pulmonary"}, {"QualifierName": ["drug therapy", "etiology", "pathology", "physiopathology"], "DescriptorName": "Hypertrophy, Right Ventricular"}, {"QualifierName": ["complications", "drug therapy", "metabolism", "parasitology"], "DescriptorName": "Hypoxia"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Medicine, Tibetan Traditional"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["metabolism", "pathology", "physiopathology"], "DescriptorName": "Pulmonary Artery"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Vascular Remodeling"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Chin K. M., Rubin L. J. Pulmonary arterial hypertension. Journal of the American College of Cardiology. 2008;51(16):1527\u20131538. doi: 10.1016/j.jacc.2008.01.024.", "ArticleIdList": ["10.1016/j.jacc.2008.01.024", "18420094"]}, {"Citation": "Crosswhite P., Sun Z. Molecular mechanisms of pulmonary arterial remodeling. Molecular Medicine. 2014;20(1):191\u2013201. doi: 10.2119/molmed.2013.00165.", "ArticleIdList": ["10.2119/molmed.2013.00165", "PMC4002851", "24676136"]}, {"Citation": "Naeije R., Dedobbeleer C. Pulmonary hypertension and the right ventricle in hypoxia. Experimental Physiology. 2013;98(8):1247\u20131256. doi: 10.1113/expphysiol.2012.069112.", "ArticleIdList": ["10.1113/expphysiol.2012.069112", "23625956"]}, {"Citation": "Naeije R., Vanderpool R. Pulmonary hypertension and chronic mountain sickness. High Altitude Medicine & Biology. 2013;14(2):117\u2013125. doi: 10.1089/ham.2012.1124.", "ArticleIdList": ["10.1089/ham.2012.1124", "23795731"]}, {"Citation": "Penaloza D., Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 2007;115(9):1132\u20131146. doi: 10.1161/CIRCULATIONAHA.106.624544.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.624544", "17339571"]}, {"Citation": "Cahill E., Rowan S. C., Sands M., et al. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: Vasoconstrictor and structural mechanisms contribute equally. Experimental Physiology. 2012;97(6):796\u2013806. doi: 10.1113/expphysiol.2012.065474.", "ArticleIdList": ["10.1113/expphysiol.2012.065474", "22366565"]}, {"Citation": "Simonneau G., Gatzoulis M., Adatia I. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology. 2013;62(25, supplement) doi: 10.1016/j.jacc.2013.10.029.", "ArticleIdList": ["10.1016/j.jacc.2013.10.029", "24355639"]}, {"Citation": "Whayne T. F. Cardiovascular medicine at high altitude. Angiology. 2014;65(6):459\u2013472. doi: 10.1177/0003319713497086.", "ArticleIdList": ["10.1177/0003319713497086", "23892441"]}, {"Citation": "Roberti di Sarsina P., Ottaviani L., Mella J. Tibetan medicine: a unique heritage of person-centered medicine. EPMA Journal. 2011;2(4):385\u2013389. doi: 10.1007/s13167-011-0130-x.", "ArticleIdList": ["10.1007/s13167-011-0130-x", "PMC3405412", "23194325"]}, {"Citation": "Luo W.-Z., Li Q.-E., Chen J., et al. Textual research for Tibetan medicine Qumazi. China journal of Chinese materia medica. 2015;40(10):2047\u20132049.", "ArticleIdList": ["26390671"]}, {"Citation": "Yang M., Zhang S., Ren S., et al. Effect of aqueous extract of Sanweitanxiang powder on calcium homeostasis protein expression in ischemic-reperfusion injury rat heart. Journal of Traditional Chinese Medicine. 2013;33(3):355\u2013360. doi: 10.1016/S0254-6272(13)60178-8.", "ArticleIdList": ["10.1016/S0254-6272(13)60178-8", "24024332"]}, {"Citation": "Shen M., Zhao L., Wu R.-X., Yue S.-Q., Pei J.-M. The vasorelaxing effect of resveratrol on abdominal aorta from rats and its underlying mechanisms. Vascular Pharmacology. 2013;58(1-2):64\u201370. doi: 10.1016/j.vph.2012.07.005.", "ArticleIdList": ["10.1016/j.vph.2012.07.005", "22820258"]}, {"Citation": "Dierick F., H\u00e9ry T., Hoareau-Coudert B., et al. Resident PW1+ progenitor cells participate in vascular remodeling during pulmonary arterial hypertension. Circulation Research. 2016;118(5):822\u2013833. doi: 10.1161/CIRCRESAHA.115.307035.", "ArticleIdList": ["10.1161/CIRCRESAHA.115.307035", "26838788"]}, {"Citation": "van Loon R. L., Bartelds B., Wagener F. A., et al. Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme oxygenase. Frontiers in Pediatrics. 2015;3(71) doi: 10.3389/fped.2015.00071.", "ArticleIdList": ["10.3389/fped.2015.00071", "PMC4551834", "26380246"]}, {"Citation": "Colleoni B., Paternot S., Pita J. M., et al. JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21. Oncogene. 2017;36(30):4349\u20134361. doi: 10.1038/onc.2017.7.", "ArticleIdList": ["10.1038/onc.2017.7", "PMC5537611", "28368408"]}, {"Citation": "Hino H., Dai P., Yoshida T., et al. Interaction of Cx43 with Hsc70 regulates G1/S transition through CDK inhibitor p27. Scientific Reports. 2015;5", "ArticleIdList": ["PMC4612729", "26481195"]}, {"Citation": "Orlando S., Gallastegui E., Besson A., et al. P27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes. Nucleic Acids Research. 2015;43(14):6860\u20136873. doi: 10.1093/nar/gkv593.", "ArticleIdList": ["10.1093/nar/gkv593", "PMC4538812", "26071952"]}, {"Citation": "Patel P., Asbach B., Shteyn E., et al. Brk/Protein Tyrosine Kinase 6 Phosphorylates p27. Molecular and Cellular Biology. 2015;35(9):1506\u20131522. doi: 10.1128/MCB.01206-14.", "ArticleIdList": ["10.1128/MCB.01206-14", "PMC4387217", "25733683"]}, {"Citation": "Detweiler N. D., Song L., McClenahan S. J., et al. BK channels in rat and human pulmonary smooth muscle cells are BK. Pulmonary Circulation. 2017;6(4):563\u2013575. doi: 10.1086/688838.", "ArticleIdList": ["10.1086/688838", "PMC5210062", "28090300"]}, {"Citation": "Modgil A., Guo L., O'Rourke S. T., Sun C. Apelin-13 inhibits large-conductance Ca2+-Activated Kchannels in cerebral artery smooth muscle cells via a PI3-Kinase dependent mechanism. PLoS ONE. 2013;8(12)", "ArticleIdList": ["PMC3873301", "24386141"]}, {"Citation": "Revermann M., Neofitidou S., Kirschning T., Schloss M., Brandes R. P., Hofstetter C. Inhalation of the BKCa -opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension. PLoS ONE. 2014;9(1)", "ArticleIdList": ["PMC3909005", "24497961"]}, {"Citation": "Wang X., Zhao T., Zhou S., Sun L., Zhang L., Yu G. Mg2+-dependent modulation of BKCa channels by genistein in rat arteriolar smooth muscle cells. Journal of Cellular Physiology. 2014;229(12):1981\u20131989. doi: 10.1002/jcp.24648.", "ArticleIdList": ["10.1002/jcp.24648", "24729485"]}, {"Citation": "Yan J., Chen R., Liu P., Gu Y. Docosahexaenoic acid attenuates hypoxic pulmonary vasoconstriction by activating the large conductance Ca2+-activated K+ currents in pulmonary artery smooth muscle cells. Pulmonary Pharmacology and Therapeutics. 2014;28(1):9\u201316. doi: 10.1016/j.pupt.2013.11.004.", "ArticleIdList": ["10.1016/j.pupt.2013.11.004", "24269522"]}, {"Citation": "Li C.-W., Cui C.-B. One new and nine known flavonoids from Choerospondias axillaries and their In Vitro antitumor, anti-hypoxia and antibacterial activities. Molecules. 2014;19(12):21363\u201321377. doi: 10.3390/molecules191221363.", "ArticleIdList": ["10.3390/molecules191221363", "PMC6271225", "25532836"]}, {"Citation": "Li C., He J., Gao Y., Xing Y., Hou J., Tian J. Preventive effect of total flavones of Choerospondias axillaries on ischemia/reperfusion-induced myocardial infarction-related MAPK signaling pathway. Cardiovascular Toxicology. 2014;14(2):145\u2013152. doi: 10.1007/s12012-013-9238-7.", "ArticleIdList": ["10.1007/s12012-013-9238-7", "24297260"]}, {"Citation": "Gee J. M., Johnson I. T. Polyphenolic compounds: Interactions with the gut and implications for human health. Current Medicinal Chemistry. 2001;8(11):1245\u20131255. doi: 10.2174/0929867013372256.", "ArticleIdList": ["10.2174/0929867013372256", "11562264"]}, {"Citation": "Kalbhen D. A. Nutmeg as a narcotic. a contribution to the chemistry and pharmacology of nutmeg myristica fragrans. Angewandte Chemie International Edition. 2010;10(6):370\u2013374. doi: 10.1002/anie.197103701.", "ArticleIdList": ["10.1002/anie.197103701", "4996769"]}, {"Citation": "Lahlou S., Figueiredo A. F., Magalh\u00e3es P. J. C., Leal-Cardoso J. H., Gloria P. D. Cardiovascular effects of methyleugenol, a natural constituent of many plant essential oils, in normotensive rats. Life Sciences. 2004;74(19):2401\u20132412. doi: 10.1016/j.lfs.2003.09.063.", "ArticleIdList": ["10.1016/j.lfs.2003.09.063", "14998717"]}, {"Citation": "Mendes-J\u00fanior L. d., Guimar\u00e3es D. D., Gadelha D. D., et al. The new nitric oxide donor cyclohexane nitrate induces vasorelaxation, hypotension, and antihypertensive effects via NO/cGMP/PKG pathway. Frontiers in Physiology. 2015;6 doi: 10.3389/fphys.2015.00243.", "ArticleIdList": ["10.3389/fphys.2015.00243", "PMC4553900", "26379557"]}, {"Citation": "Deng Y., Ng E. S. K., Kwan Y. W., et al. Cerebral vasodilator properties of Danshen and Gegen: A study of their combined efficacy and mechanisms of actions. Phytomedicine. 2014;21(4):391\u2013399. doi: 10.1016/j.phymed.2013.09.016.", "ArticleIdList": ["10.1016/j.phymed.2013.09.016", "24192211"]}, {"Citation": "Qu Z., Zhang J., Gao W., et al. Vasorelaxant effects of Cerebralcare Granule\u00ae are mediated by NO/cGMP pathway, potassium channel opening and calcium channel blockade in isolated rat thoracic aorta. Journal of Ethnopharmacology. 2014;155(1):572\u2013579. doi: 10.1016/j.jep.2014.05.062.", "ArticleIdList": ["10.1016/j.jep.2014.05.062", "24924524"]}, {"Citation": "Szappanos H. C., Viola H., Hool L. C. L-type calcium channel: Clarifying the \u201coxygen sensing hypothesis\u201d. The International Journal of Biochemistry & Cell Biology. 2017;86:32\u201336. doi: 10.1016/j.biocel.2017.03.010.", "ArticleIdList": ["10.1016/j.biocel.2017.03.010", "28323207"]}, {"Citation": "Dunham-Snary K. J., Wu D., Sykes E. A., et al. Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine. CHEST. 2017;151(1):181\u2013192. doi: 10.1016/j.chest.2016.09.001.", "ArticleIdList": ["10.1016/j.chest.2016.09.001", "PMC5310129", "27645688"]}, {"Citation": "Hayabuchi Y. The action of smooth muscle cell potassium channels in the pathology of pulmonary arterial hypertension. Pediatric Cardiology. 2017;38(1)", "ArticleIdList": ["27826710"]}, {"Citation": "Johar D. Cytoskeletal remodeling and regulation of cell fate in the hypertensive neonatal pulmonary artery in response to stress. Journal of Cellular Physiology. 2018;233(3):2146\u20132161. doi: 10.1002/jcp.25950.", "ArticleIdList": ["10.1002/jcp.25950", "28407237"]}, {"Citation": "Lyle M. A., Davis J. P., Brozovich F. V. Regulation of pulmonary vascular smooth muscle contractility in pulmonary arterial hypertension: Implications for therapy. Frontiers in Physiology. 2017;8", "ArticleIdList": ["PMC5572347", "28878690"]}, {"Citation": "Christou H., Hudalla H., Michael Z., et al. Impaired pulmonary arterial vasoconstriction and nitric oxide\u2013Mediated relaxation underlie severe pulmonary hypertension in the sugen-Hypoxia rat model. The Journal of Pharmacology and Experimental Therapeutics. 2018;364(2):258\u2013274. doi: 10.1124/jpet.117.244798.", "ArticleIdList": ["10.1124/jpet.117.244798", "PMC5774216", "29212831"]}, {"Citation": "Gai X.-Y., Wei Y.-H., Zhang W., et al. Echinacoside induces rat pulmonary artery vasorelaxation by opening the NO-cGMP-PKG-BKCa channels and reducing intracellular Ca2+ levels. Acta Pharmacologica Sinica. 2015;36(5):587\u2013596. doi: 10.1038/aps.2014.126.", "ArticleIdList": ["10.1038/aps.2014.126", "PMC4422939", "25864652"]}, {"Citation": "Barnett C. F., Alvarez P., Park M. H. Pulmonary Arterial Hypertension: Diagnosis and Treatment. Cardiology Clinics. 2016;34(3):375\u2013389. doi: 10.1016/j.ccl.2016.04.006.", "ArticleIdList": ["10.1016/j.ccl.2016.04.006", "27443135"]}, {"Citation": "Forfia P. R., Trow T. K. Diagnosis of pulmonary arterial hypertension. Clinics in Chest Medicine. 2013;34(4):665\u2013681. doi: 10.1016/j.ccm.2013.09.001.", "ArticleIdList": ["10.1016/j.ccm.2013.09.001", "24267297"]}, {"Citation": "Lan B., Hayama E., Kawaguchi N., Furutani Y., Nakanishi T. Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension. PLoS ONE. 2015;10(1)", "ArticleIdList": ["PMC4309681", "25629315"]}, {"Citation": "Zhang S., Wang M., Li Q., Zhu P. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR. Cancer Biomarkers. 2017;21(1):189\u2013196.", "ArticleIdList": ["29081412"]}, {"Citation": "Boser S. R., Mauad T., Ara\u00fajo-Paulino B. B., et al. Myofibroblasts are increased in the lung parenchyma in asthma. PLoS ONE. 2017;12(8):p. e0182378. doi: 10.1371/journal.pone.0182378.", "ArticleIdList": ["10.1371/journal.pone.0182378", "PMC5546673", "28787016"]}, {"Citation": "Fouty B. W., Grimison B., Fagan K. A., et al. p27Kip1 is important in modulating pulmonary artery smooth muscle cell proliferation. American Journal of Respiratory Cell and Molecular Biology. 2001;25(5):652\u2013658. doi: 10.1165/ajrcmb.25.5.4592.", "ArticleIdList": ["10.1165/ajrcmb.25.5.4592", "11713109"]}, {"Citation": "Ke R., Liu L., Zhu Y., et al. Knockdown of AMPK\u03b12 promotes pulmonary arterial smooth muscle cells proliferation via mTOR/Skp2/p27Kip1 signaling pathway. International Journal of Molecular Sciences. 2016;17(6):p. 844. doi: 10.3390/ijms17060844.", "ArticleIdList": ["10.3390/ijms17060844", "PMC4926378", "27258250"]}, {"Citation": "Luo Y., Xu D.-Q., Dong H.-Y., et al. Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway. PLoS ONE. 2013;8(2)", "ArticleIdList": ["PMC3578942", "23437233"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "29"}, {"Year": "2018", "Month": "10", "Day": "23"}, {"Year": "2018", "Month": "11", "Day": "1"}, {"Year": "2019", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["30622966", "PMC6304203", "10.1155/2018/9504158"]}}]}